Dyadic International, Inc.
DYAIDyadic International, Inc. is a biotechnology company that specializes in the development and manufacturing of enzymes and microbial proteins using its proprietary C1 expression platform. The company focuses on providing solutions for various industries, including pharmaceuticals, bioenergy, agriculture, and food. Dyadic's technology enables efficient production of proteins at a large scale, supporting applications such as biopharmaceuticals, enzyme-based products, and industrial enzymes.
Company News
Dyadic International announced expansion of its bio-industrial pipeline with a new proprietary industrial enzyme program for advanced cellulose processing, building on the success of EN3ZYME™. The program leverages the company's Dapibus™ platform to develop tailored enzyme solutions for pulp biorefining, microcrystalline cellulose, and nanoce...
Dyadic International, Inc. (Nasdaq: DYAI), a biotechnology company specializing in precision-engineered proteins and enzymes, will deliver a live interactive presentation at the Skyline Signature Series on May 27, 2026 at 12:00 PM ET. The event will allow investors to ask questions in real time and requires pre-registration.
Dyadic International, Inc., a biotechnology company focused on large-scale protein manufacturing, announced it will report Q1 2025 financial results and host a corporate update call on May 14, 2025.
The global industrial enzymes market is expected to grow from $7.03 billion in 2024 to $12.05 billion by 2033, driven by the increasing demand for sustainable manufacturing and the growing use of enzymes in various industries. The report analyzes the market by types, applications, sources, and countries, and provides insights on key players in th...
Dyadic International, a biotechnology company, announced its participation in several industry events worldwide, including the Developing Countries Vaccine Manufacturers Network (DCVMN) Int'l Annual Meeting 2024, the World Vaccine Congress Europe 2024, and BIO-Europe. The company aims to showcase its proprietary C1 and Dapibus™ technology platf...
